Authors
Loading...
Preclinical study demonstrates potent antitumor efficacy of a di-iron(I) complex in cancer models, indicating strong potential as a stable alternative to cisplatin.
Franco et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: